Skip to main content
Top
Published in: Clinical Rheumatology 12/2019

01-12-2019 | Systemic Lupus Erythematosus | Original Article

Analysis of the clinical characteristics of thirteen patients with Weber-Christian panniculitis

Authors: Wei Zheng, Wenyuan Song, Qingqing Wu, Qiaoqiao Yin, Chaolan Pan, Hongying Pan

Published in: Clinical Rheumatology | Issue 12/2019

Login to get access

Abstract

Background

Weber-Christian disease (WCD) is an uncommon, idiopathic disease that is challenging to diagnose and has an unclear treatment protocol. We reviewed thirteen patients with WCD and analyzed their clinical characteristics. The purpose of this article was to improve the understanding of this rare disorder.

Methods

Thirteen cases of WCD were analyzed retrospectively regarding their clinical manifestation, laboratory results, misdiagnoses, therapy, and outcome.

Results

Of the thirteen patients diagnosed with WCD, the majority were female (male to female ratio, 2:11), with a mean patient age of 50.1 years. Subcutaneous nodules were the most commonly reported symptom, followed by fever, arthralgias/arthritis, and myalgia. The laboratory results were typically nonspecific. In total, 61.5% patients were misdiagnosed before pathology confirmed the diagnosis of WCD. Most patients were treated with corticosteroids and/or immunosuppressants. Two patients were treated surgically. While long-term remission was successfully achieved in some patients, others had recurrent symptoms.

Conclusion

WCD was predominantly observed in female patients in our cohort. Subcutaneous nodules and fever were the most common clinical characteristics. In addition, the patients’ laboratory test results were nonspecific, which led to a high misdiagnosis rate. In this study population, corticosteroid and/or immunosuppressant treatments were efficacious therapeutic interventions for WCD.
Key Points
Subcutaneous nodules and fever were the most common clinical characteristics in Weber-Christian panniculitis.
Misdiagnosis rate was higher in Weber-Christian panniculitis patient; tumors, bacterial infections and rheumatic diseases were the most common misdiagnoses.
Corticosteroid and/or immunosuppressant therapy was effective in most Weber-Christian panniculitis patients.
Literature
2.
go back to reference Weber FP (1925) A case of relapsing nonsuppurative pannicultis showing phagocytosis of subcutaneous fat cells by macrophages. Br J Dermatol 37:301–311CrossRef Weber FP (1925) A case of relapsing nonsuppurative pannicultis showing phagocytosis of subcutaneous fat cells by macrophages. Br J Dermatol 37:301–311CrossRef
3.
go back to reference Christian HA (1928) Relapsing febrile nodular nonsuppurative panniculitis. Arch Intern Med 42:338–351CrossRef Christian HA (1928) Relapsing febrile nodular nonsuppurative panniculitis. Arch Intern Med 42:338–351CrossRef
4.
go back to reference Bailey RJ (1937) Relapsing febrile nodular nonsuppurative panniculitis (Weber-Christian disease). JAMA 109:1419–1425CrossRef Bailey RJ (1937) Relapsing febrile nodular nonsuppurative panniculitis (Weber-Christian disease). JAMA 109:1419–1425CrossRef
Metadata
Title
Analysis of the clinical characteristics of thirteen patients with Weber-Christian panniculitis
Authors
Wei Zheng
Wenyuan Song
Qingqing Wu
Qiaoqiao Yin
Chaolan Pan
Hongying Pan
Publication date
01-12-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04722-y

Other articles of this Issue 12/2019

Clinical Rheumatology 12/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine